Limba
Romanian
Romanian
English|
Cirtuvivint (SM08502) is a potent and orally active inhibitor of CDC-like kinase (CLK)and a DYRK(dual-specificity tyrosine kinase) that targets mRNA splicing and is optimized for Wnt pathway inhibition. Cirtuvivint inhibits serine and arginine-rich splicing factor (SRSF) phosphorylation and disrupts spliceosome activity. Cirtuvivint can be used for solid tumor research.
| Price | 2.846,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Cirtuvivint (SM08502) is a potent and orally active inhibitor of CDC-like kinase (CLK)and a DYRK(dual-specificity tyrosine kinase) that targets mRNA splicing and is optimized for Wnt pathway inhibition. Cirtuvivint inhibits serine and arginine-rich splicing factor (SRSF) phosphorylation and disrupts spliceosome activity. Cirtuvivint can be used for solid tumor research. |
